About

Dan Spivey is an associate in the Life Sciences Regulatory team. Dan advises clients in the pharmaceutical, healthcare, medical device, and food and beverage sectors…

Dan Spivey is an associate in the Life Sciences Regulatory team. Dan advises clients in the pharmaceutical, healthcare, medical device, and food and beverage sectors on a range of regulatory matters.

UK Government to Recognize CE Marks Indefinitely (other than for Medical Devices and IVDs)

August 16, 2023

New MHRA Guidance on the Windsor Framework: Timings Confirmed but More Details to Follow

June 21, 2023

Update on the VPAS Judicial Review brought by the British Generic Manufacturers Association

June 1, 2023

EU Pharma Legislation Review Series: Advertising Updates Reflect Evolution Rather than Revolution

May 3, 2023

Legislative Proposals for Clinical Trials Aim to Streamline, Simplify and Stimulate UK-based Innovation

April 17, 2023

CJEU Provides Further Clarifications on Food for Special Medical Purposes

March 14, 2023

Myriam Zilles, Unsplash

Notified body capacity needed! MDCG proposals recognize need to increase notified body capacity to ensure device availability

September 18, 2022

About

Dan Spivey is an associate in the Life Sciences Regulatory team. Dan advises clients in the pharmaceutical, healthcare, medical device, and food and beverage sectors…

Dan Spivey is an associate in the Life Sciences Regulatory team. Dan advises clients in the pharmaceutical, healthcare, medical device, and food and beverage sectors on a range of regulatory matters.

Connect:

Subscribe:

Blogs